Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

VERU Relative to the S&P 500

VERU Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Veru Inc. (NASD:VERU) seasonal charts above shows that a Buy Date of November 16 and a Sell Date of February 11 has resulted in a geometric average return of 8.56% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 13 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 26.35% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Consumer Staples sector, which runs from April 25 to November 23. The seasonal chart for the broad sector is available via the following link: Consumer Staples Sector Seasonal Chart.

Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines and treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. The company was founded by William R. Gargiulo, Jr. and O. B. Parrish in 1971 and is headquartered in Miami, FL.

To download VERU seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: VERU